🚀 VC round data is live in beta, check it out!
- Public Comps
- enVVeno Medical
enVVeno Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for enVVeno Medical and similar public comparables like Bioretec, Pheton Holdings, Carmat, BibbInstruments and more.
enVVeno Medical Overview
About enVVeno Medical
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Founded
1999
HQ

Employees
37
Website
Financials (FY)
Market Cap
$8M
enVVeno Medical Financials
enVVeno Medical reported last fiscal year revenue of — and negative EBITDA of ($20M).
In the same fiscal year, enVVeno Medical generated ($20M) in EBITDA losses and had net loss of ($19M).
Revenue (LTM)
enVVeno Medical P&L
In the most recent fiscal year, enVVeno Medical reported revenue of — and EBITDA of ($20M).
enVVeno Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($20M) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($19M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
enVVeno Medical Stock Performance
enVVeno Medical has current market cap of $8M.
Market Cap Evolution
enVVeno Medical's stock price is $11.70.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $8M | 0.0% | XXX | XXX | XXX | $-29.70 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialenVVeno Medical Valuation Multiples
enVVeno Medical trades at 1.0x EV/EBITDA.
EV / Revenue (LTM)
enVVeno Medical Financial Valuation Multiples
As of April 20, 2026, enVVeno Medical has market cap of $8M.
Equity research analysts estimate enVVeno Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
enVVeno Medical has a P/E ratio of (0.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $8M | XXX | $8M | XXX | XXX | XXX |
| EV (current) | ($20M) | XXX | ($20M) | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 0.9x | XXX | XXX | XXX |
| P/E | — | XXX | (0.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 1.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified enVVeno Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


enVVeno Medical Margins & Growth Rates
enVVeno Medical's revenue in the last fiscal year grew by —.
enVVeno Medical's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.6M for the same period.
enVVeno Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | (12%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
enVVeno Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| enVVeno Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Bioretec | XXX | XXX | XXX | XXX | XXX | XXX |
| Pheton Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Carmat | XXX | XXX | XXX | XXX | XXX | XXX |
| BibbInstruments | XXX | XXX | XXX | XXX | XXX | XXX |
| Zynex | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
enVVeno Medical M&A Activity
enVVeno Medical acquired XXX companies to date.
Last acquisition by enVVeno Medical was on XXXXXXXX, XXXXX. enVVeno Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by enVVeno Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialenVVeno Medical Investment Activity
enVVeno Medical invested in XXX companies to date.
enVVeno Medical made its latest investment on XXXXXXXX, XXXXX. enVVeno Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by enVVeno Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout enVVeno Medical
| When was enVVeno Medical founded? | enVVeno Medical was founded in 1999. |
| Where is enVVeno Medical headquartered? | enVVeno Medical is headquartered in United States. |
| How many employees does enVVeno Medical have? | As of today, enVVeno Medical has over 37 employees. |
| Who is the CEO of enVVeno Medical? | enVVeno Medical's CEO is Robert A. Berman. |
| Is enVVeno Medical publicly listed? | Yes, enVVeno Medical is a public company listed on Nasdaq. |
| What is the stock symbol of enVVeno Medical? | enVVeno Medical trades under NVNO ticker. |
| When did enVVeno Medical go public? | enVVeno Medical went public in 2018. |
| Who are competitors of enVVeno Medical? | enVVeno Medical main competitors are Bioretec, Pheton Holdings, Carmat, BibbInstruments. |
| What is the current market cap of enVVeno Medical? | enVVeno Medical's current market cap is $8M. |
| Is enVVeno Medical profitable? | No, enVVeno Medical is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.